Global Cord Blood Corporation CO

$ 2.99 0.0%

Annual report 2022
added 08-16-2022

Global Cord Blood Corporation Financial Statements 2011-2024 | CO

Annual Financial Statements Global Cord Blood Corporation

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	243 M	486 M	365 M	818 M	1.12 B	555 M	456 M	460 M	314 M	207 M	217 M	236 M
Shares	122 M	122 M	122 M	121 M	119 M	73 M	73 M	73 M	73 M	71.5 M	73.9 M	70.1 M
Historical Prices	2.5	4	3.87	4.65	6.28	10.2	5.75	5.86	4.58	3.87	2.57	2.48
Net Income	501 M	508 M	471 M	291 M	237 M	126 M	91 M	107 M	132 M	112 M	132 M	91.7 M
Revenue	1.24 B	1.16 B	1.22 B	987 M	937 M	760 M	663 M	635 M	573 M	526 M	380 M	340 M
Cost of Revenue	183 M	179 M	189 M	186 M	181 M	143 M	-	-	-	107 M	86.7 M	77.4 M
Gross Profit	1.06 B	981 M	1.03 B	801 M	755 M	617 M	518 M	505 M	467 M	420 M	294 M	262 M
Operating Income	609 M	545 M	559 M	382 M	280 M	265 M	191 M	235 M	232 M	209 M	135 M	124 M
Interest Expense	6.27 M	8.16 M	7.39 M	5.7 M	3.26 M	119 M	108 M	101 M	70.1 M	70.1 M	3.29 M	2.61 M
EBITDA	652 M	589 M	604 M	434 M	330 M	313 M	233 M	286 M	269 M	245 M	164 M	147 M
Operating Expenses	451 M	436 M	473 M	419 M	475 M	352 M	327 M	270 M	235 M	210 M	159 M	138 M
General and Administrative Expenses	187 M	174 M	190 M	424 M	483 M	380 M	326 M	265 M	231 M	205 M	161 M	139 M

All numbers in CNY currency

Quarterly Income Statement Global Cord Blood Corporation

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	122 M	-	122 M	-	122 M	-	122 M	-	122 M	-	122 M	-	122 M	-	121 M	-	121 M	-	114 M	-	73 M	-	73 M	-	73 M	-	73 M	-	73 M	-	73 M	-	73 M	-	73 M	73 M	73 M	-	69.9 M	73.1 M	73.1 M	73.2 M	74.5 M	-	75.4 M
Net Income	-	-	-	-	-	126 M	-	-	-	131 M	-	-	-	120 M	-	-	-	65.1 M	-	-	-	67.6 M	-	-	-	16.6 M	-	-	-	18.7 M	-	-	-	27.2 M	-	-	-	24.9 M	32.9 M	-	-	24.7 M	31.1 M	29.2 M	39.5 M	23.2 M	40 M	26.3 M
Revenue	-	-	-	-	-	314 M	-	-	-	286 M	-	-	-	313 M	-	-	-	247 M	-	-	-	235 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	142 M	129 M	-	-	128 M	115 M	99.8 M	94.8 M	98.4 M	87.5 M	94.7 M
Cost of Revenue	-	-	-	-	-	46.2 M	-	-	-	44.7 M	-	-	-	48.3 M	-	-	-	47.3 M	-	-	-	45.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	27.4 M	24.5 M	-	-	27.1 M	24.4 M	23.3 M	21.7 M	21.8 M	19.9 M	20 M
Gross Profit	-	-	-	-	-	267 M	-	-	-	241 M	-	-	-	265 M	-	-	-	200 M	-	-	-	189 M	-	-	-	145 M	-	-	-	134 M	-	-	-	122 M	-	-	-	114 M	104 M	-	-	101 M	90.9 M	76.4 M	73.1 M	76.7 M	67.6 M	74.7 M
Operating Income	-	-	-	-	-	160 M	-	-	-	139 M	-	-	-	144 M	-	-	-	105 M	-	-	-	76.3 M	-	-	-	54.7 M	-	-	-	52.5 M	-	-	-	57.5 M	-	-	-	56.3 M	45.9 M	-	-	47 M	44.4 M	34.8 M	31.5 M	37.7 M	30.8 M	36.4 M
Interest Expense	-	-	-	-	-	583 K	-	-	-	1.2 M	-	-	-	422 K	-	-	-	-56 K	-	-	-	993 K	-	-	-	29.8 M	-	-	-	26.3 M	-	-	-	25.2 M	-	-	-	16.5 M	14.8 M	-	-	14.1 M	10.2 M	896 K	741 K	1.19 M	460 K	657 K
EBITDA	-	-	-	-	-	172 M	-	-	-	150 M	-	-	-	156 M	-	-	-	117 M	-	-	-	87.5 M	-	-	-	66.2 M	-	-	-	63.9 M	-	-	-	69.6 M	-	-	-	63.8 M	45.9 M	-	-	54.2 M	44.4 M	34.8 M	31.5 M	43.7 M	30.8 M	36.4 M
Operating Expenses	-	-	-	-	-	107 M	-	-	-	102 M	-	-	-	121 M	-	-	-	95.1 M	-	-	-	113 M	-	-	-	90.3 M	-	-	-	81.8 M	-	-	-	64.3 M	-	-	-	58 M	58.3 M	-	-	54.4 M	46.5 M	41.6 M	41.6 M	39 M	36.8 M	38.2 M
General and Administrative Expenses	-	-	-	-	-	44.5 M	-	-	-	42.7 M	-	-	-	49.4 M	-	-	-	40 M	-	-	-	52.8 M	-	-	-	48.3 M	-	-	-	42.6 M	-	-	-	31 M	-	-	-	28 M	27.4 M	-	-	29 M	25.1 M	23.1 M	22.7 M	21.4 M	22.5 M	23.3 M

All numbers in CNY currency